52 results on '"Mahler, Donald A."'
Search Results
2. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD
3. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review
4. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
5. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers
6. The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease
7. Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3)
8. Indacaterol vs tiotropium in COPD patients classified as GOLD A and B
9. Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity
10. Inflammation in COPD: Implications for Management
11. Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD
12. Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy
13. American College of Chest Physicians Consensus Statement on the Management of Dyspnea in Patients With Advanced Lung or Heart Disease
14. Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease
15. Perceptual and Physiologic Responses During Treadmill and Cycle Exercise in Patients With COPD
16. REMOTELY RECORDED PEAK INHALATION FLOW PATTERNS AMONG PATIENTS WITH COPD USING PROAIR DIGIHALER FOR RESCUE MEDICATION
17. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
18. Dexamethasone for cancer-related dyspnoea – Authors' reply
19. Meaningful effect size and patterns of response of the transition dyspnea index
20. Evaluation of dyspnea in the elderly
21. Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD
22. How Should Health-Related Quality of Life Be Assessed in Patients With COPD?
23. Efficacy of Salmeterol Xinafoate in the Treatment of COPD
24. Enhanced Drug and Device Development by Targeting “Relief of Dyspnea”
25. PREDICTORS OF SUBOPTIMAL PEAK INSPIRATORY FLOW RATE IN PATIENTS WITH COPD: ANALYSES FROM THE REVEFENACIN PHASE-3 PROGRAM
26. Chapter 19 - Dyspnea
27. Patients With Severe COPD Show Significant Improvements in Dyspnea and Lung Function With Once-Daily QVA149: The Blaze Study
28. Once-Daily QVA149 Demonstrates Superior Improvements in Patient-Reported Dyspnea Compared to Tiotropium in Patients With Moderate-to-Severe COPD: The BLAZE Study
29. Development and Validation of an Innovative Self-Administered Computerized Version of Baseline/Transition Dyspnea Index for Evaluating Breathlessness in Patients With COPD: The BLAZE Study
30. Antagonism of Substance P and Perception of Dyspnea and Pain in Patients With COPD
31. Predictors of Peak Inspiratory Flow Rate (PIFR) in Advanced COPD
32. Intralobar Pulmonary Sequestration in an Adult
33. Contributors
34. Responsiveness of Self-Reported Dyspnea Instruments in Patients With Chronic Obstructive Pulmonary Disease
35. EFFECT OF ARFORMOTEROL TWICE DAILY, TIOTROPIUM ONCE DAILY, AND THEIR COMBINATION IN SUBJECTS WITH COPD
36. Colaboradores
37. COMPREHENSIVE MEASUREMENT OF BREATHLESSNESS USING THE SELF-ADMINISTERED COMPUTERIZED VERSIONS OF THE BASELINE AND TRANSITION DYSPNEA INDEXES
38. CONTRIBUTORS
39. Are You Fluent in the Language of Dyspnea?
40. Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disease
41. Dyspnea Ratings for Prescription of Cross-Modal Exercise in Patients With COPD
42. Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With COPD
43. Acute Effects of Passive Smoking on Lung Function and Airway Reactivity in Asthmatic Subjects
44. Impact of Dyspnea and Physiologic Function on General Health Status in Patients with Chronic Obstructive Pulmonary Disease
45. Measurement of Respiratory Sensation in Interstitial Lung Disease: Evaluation of Clinical Dyspnea Ratings and Magnitude Scaling
46. Salmeterol Reduces Dyspnea and Improves Lung Function in Patients With COPD
47. Right Ventricular Function at Rest and during Exercise in Chronic Obstructive Pulmonary Disease
48. The Role of Theophylline in the Treatment of Dyspnea in COPD
49. Positional Dyspnea and Oxygen Desaturation Related to Carcinoma of the Lung: Up with the Good Lung
50. Looped Bronchoscope
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.